Scarica l'app Stockscreener
2.28
88.43%
1.07
Pre-mercato:
1.97
-0.31
-13.60%
Precedente Chiudi:
$1.21
Aprire:
$3.055
Volume 24 ore:
136.34M
Relative Volume:
55.72
Capitalizzazione di mercato:
$67.86M
Reddito:
-
Utile/perdita netta:
$-13.08M
Rapporto P/E:
-5.163
EPS:
-0.4416
Flusso di cassa netto:
-
1 W Prestazione:
+96.55%
1M Prestazione:
+29.55%
6M Prestazione:
-51.39%
1 anno Prestazione:
-41.39%
Intervallo 1D:
$2.04
$3.10
Intervallo di 1 settimana:
$1.13
$3.10
Portata 52W:
$1.12
$8.40
Telomir Pharmaceuticals Inc Stock (TELO) Company Profile
Nome
Telomir Pharmaceuticals Inc
Settore
Industria
Telefono
786-396-6723
Indirizzo
100 SE 2ND ST, MIAMI
Confronta TELO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TELO
Telomir Pharmaceuticals Inc
|
2.28 | 34.52M | 0 | -13.08M | 0 | -0.4416 |
|
VRTX
Vertex Pharmaceuticals Inc
|
459.81 | 120.40B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
542.52 | 61.30B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.53 | 41.06B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
564.59 | 34.29B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.55 | 27.09B | 3.81B | -644.79M | -669.77M | -6.24 |
Telomir Pharmaceuticals Inc Stock (TELO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-21 | Iniziato | Rodman & Renshaw | Buy |
Telomir Pharmaceuticals Inc Borsa (TELO) Ultime notizie
Is Telomir Pharmaceuticals Inc. a good long term investmentSuperior investment outcomes - Autocar Professional
What analysts say about Telomir Pharmaceuticals Inc. stockTremendous growth opportunities - Autocar Professional
What drives Telomir Pharmaceuticals Inc. stock priceDynamic investment opportunities - Autocar Professional
Why Is Telomir Pharmaceuticals Stock (TELO) Up 150% Today? - MSN
Telomir Demonstrates Telomir-1 Reverses Epigenetic Gene Silencing of STAT1, Restoring Tumor Suppressor in Human Prostate Cancer Cells, Outperforming Chemotherapy and Rapamycin - Lohud
Telomir Pharmaceuticals Stock Price, Quotes and Forecasts - Benzinga
Telomir skyrockets on preclinical data backing epigenetic potential of lead asset - FirstWord Pharma
Telomir Pharmaceuticals Inc. Stock Analysis and ForecastFree Stock Movement Tracking - jammulinksnews.com
Dow Falls Over 200 Points; 3M Earnings Top Views - Benzinga
Telomir Pharma Skyrockets Nearly 139% After-Hours As Cancer Drug Shows Breakthrough Results, Beats Chemo In Human Cell Tests - NewsBreak: Local News & Alerts
Telomir Pharmaceuticals Skyrockets 150% on Breakthrough Preclinical Cancer Results - MSN
Telomir Pharmaceuticals: A Disruptive Force in Prostate Cancer Therapy with Epigenetic Innovation - AInvest
Telomir Pharmaceuticals stock soars after promising cancer treatment data - Investing.com
Telomir Pharma Jumps In After-Hours Trading After Drug Reverses Damage In Progeria Cells; Retail Eyes Bigger Gains - Stocktwits
Telomir Pharmaceuticals stock soars after promising cancer treatment data By Investing.com - Investing.com UK
Cancer Breakthrough Sends Telomir Pharma Stock Exploding 157% - Wall Street Pit
Telomir-1 shows stronger epigenetic effects than standard drugs in cancer study - Investing.com Australia
Telomir-1 shows stronger epigenetic effects than standard drugs in cancer study By Investing.com - Investing.com South Africa
Revolutionary Cancer Treatment Shows 50% Tumor Reduction, Beats Standard Chemotherapy in Clinical Tests - Stock Titan
TELO’s Stock Tango: The Dance of Gains and Losses in 2025 - investchronicle.com
Published on: 2025-07-18 16:06:06 - jammulinksnews.com
Telomir Pharmaceuticals Stock Soars 123.97% on Promising Cancer Drug Data - AInvest
Telomir Pharma Jumps In After-Hours Trading After Drug Reverses Damage In Progeria Cells Retail Eyes Bigger Gains - Menafn.com
Telomir says data show Telomir-1 reversed epigenetic silencing - TipRanks
What makes Telomir Pharmaceuticals Inc. stock price move sharplySmart Money Trade Setups - Newser
How Telomir Pharmaceuticals Inc. stock performs during market volatilityProfit Focused Trade Alerts - Newser
Why Telomir Pharmaceuticals Inc. stock attracts strong analyst attentionStable Stocks With High Yield - Newser
Telomir Pharmaceuticals (NASDAQ:TELO) Trading Down 18.3% – Should You Sell? - Defense World
Telomir Pharmaceuticals, Inc.(NasdaqCM: TELO) dropped from Russell 3000 Value Index - MarketScreener
TELO Rises on Promising Telomir-1 Preclinical Results - MSN
Telomir Pharmaceuticals Prevents Cellular Aging in Patient-Derived Cells from Children with Progeriaan Ultra-Rare Genetic Disorder that Causes Rapid Aging - Knoxville News Sentinel
# Telomir-1 shows anti-aging effects in progeria cell study By Investing.com - Investing.com South Africa
Telomir Pharmaceuticals reports positive results for progeria treatment By Investing.com - Investing.com South Africa
Telomir Pharmaceuticals reports positive results for progeria treatment - Investing.com
# Telomir-1 shows anti-aging effects in progeria cell study - Investing.com Australia
Telomir Pharmaceuticals IncTelomir-1 Significantly Increased Cell ViabilitySEC Filing - MarketScreener
Telomir Pharmaceuticals Inc Azioni (TELO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.59%
0.34%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):